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Ocular manifestations in congenital
toxoplasmosis
Abstract Background: Retinocho-
roiditis is the most common ocular
manifestation of congenital toxoplas-
mosis, but other associated ophthal-
mological pathologies can also occur.
The aim of this study was to deter-
mine the nature of the latter in treated
cases of the disease and to assess their
impact on visual function. Methods:
Four hundred and thirty consecutive
children with serologically confirmed
congenital toxoplasmosis were in-
cluded in this study. Data were
prospectively collected using
standardized ophthalmological as-
sessment forms. The presence of
retinochoroiditis and of associated
pathologies was ascertained, and their
impact on visual function was as-
sessed. Results: After a median
follow-up of 12 years [range 0.6–26
years], 130 children manifested
retinochoroiditis. We detected 22 foci
of retinochoroiditis at birth and 264
additional ones during the follow-up
period. Of these, 48 (17%) were
active when first diagnosed. Twenty-
five of the 130 children (19%) had
other associated ocular pathologies.
Of these, 21 (16%) had a strabismus,
which was due to macular lesions in
86% of the cases; 7 (5.4%) presented
with unilateral microphthalmia, and 4
(3%) with cataracts. Most of these
events were detected after the onset of
retinochoroiditis. None of the children
presented with ocular involvement in
the absence of chorioretinal lesions.
Macular lesions occurred more fre-
quently in children with associated
pathologies (p<0.0001), and asso-
ciated pathologies were likewise more
common in individuals with macular
lesions (p=0.0003). Visual impair-
ment occurred in 31/130 cases, and in
all but 3 of these eyes it was due not
to an associated pathology but to
macular retinochoroiditis.
Conclusions: At the end of the fol-
low-up period, ocular involvement
existed in 30% of the treated children
with congenital toxoplasmosis. Asso-
ciated eye pathologies were mani-
fested less frequently than anticipated.
They may occur later in life and are
an indirect marker of the severity of
congenital toxoplasmosis, but they do
not have a direct impact on visual
acuity. The overall functional prog-
nosis of congenital toxoplasmosis is
better than would be expected on the
basis of literature findings, with only
2 of the 130 children suffering bilat-
eral visual impairment.
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Introduction
Retinochoroiditis is the most frequently described ocular
manifestation of congenital toxoplasmosis [4, 12, 14]. Only
a few reports have paid attention to other associated eye
pathologies, even though these exist in at least 34% of
cases [3, 4, 11, 12, 18]. The associated ocular pathologies
that most frequently contribute to an impaired visual func-
tion are strabismus, microphthalmia, cataract, retinal detach-
ment, atrophy of the optic nerve, iridocyclitis, nystagmus,
glaucoma, choroidal neovascularization and phthisis. With
the exception of microphthalmia, little is known concerning
the time of onset and the consequences of these associated
pathologies. More information would help practitioners to
better estimate the real impact of toxoplasmosis on visual
impairment and public health.
In a consecutive series of children with serologically
confirmed congenital toxoplasmosis, we therefore docu-
mented all ocular pathologies and assessed their impact on
visual function.
Methods
Participants
A total of 430 consecutive children with confirmed congen-
ital toxoplasmosis were monitored at the Croix-Rousse Hos-
pital, Lyon, France, from the time of their birth (between
March 1975 and October 2001). Selection was based on
congenital child infection before 1989 (n=103) and on ma-
ternal infection and intrauterine transmission in or after
1989 (n=327), when mandatory prenatal screening was
introduced.
Definitions of maternal and congenital infection and
recommendations for treatment and surveillance have been
previously published by ourselves [19, 20]. Maternal in-
fection was defined as the appearance of specific IgG in
previously seronegative women, or as a significant rise in
specific IgG in women who registered positive for specif-
ic IgM. All children had persistently raised levels of spe-
cific IgG after the first postnatal year, thereby confirming
the presence of congenital toxoplasmosis. Other evidence
included: positive findings after the inoculation of mice
with amniotic fluid or umbilical-cord blood, up to 1994,
and positive PCR and amniotic fluid results thereafter;
the presence of specific IgM and IgA in foetal blood; the
presence after birth of specific IgM (index >2) [ISAGA
(Biomérieux, Marcy l’Etoile, France)], and of specific IgA
(>0.70) [ELISA (SFRI, Bordeaux, France)]; or patent
clinical signs of toxoplasmosis. Standard maternal treat-
ment included the administration of spiramycin (3 g/day)
until the time of delivery. When the infection occurred
after the 32nd week of pregnancy, or when foetal infection
was confirmed prenatally, women underwent a 3-week
course of treatment with sulphadiazine (3 g/day), pyri-
methamine (50 mg/day) and folinic acid (50 mg every
7 days per os). Neonates with confirmed or suspected con-
genital toxoplasmosis initially underwent a 3-week course
of treatment with pyrimethamine (3 mg/kg of body weight
every 3 days), sulphadiazine (25 mg/kg of body weight
every 8 h) and folinic acid (50 mg every 7 days), with
weekly haematological and renal monitoring. At 2 months
of age, a 12-month course of treatment with pyrimeth-
amine (1.25 mg/kg of body weight every 10 days), sul-
phadoxine (Fansidar; 25 mg/kg of body weight every 10
days) and folinic acid (50 mg orally every 7 days) was
instigated, with monthly haematological surveillance. If an
active retinal lesion was detected during this time, treatment
with Fansidar was continued for a further 3 months.
Collection of ophthalmological data
Ophthalmological examinations were undertaken at birth,
every 3 months for the first 2 years of life, every 6 months
during the 3rd year, and annually thereafter. At each visit,
visual function was assessed, and the anterior and posterior
segments of both eyes were examined after pupillary di-
latation either using a slit-lamp, or by direct ophthalmos-
copy using a three-mirror Goldmann contact lens for direct
visualization and/or a wide-field lens for indirect visual-
ization of the retina, depending on the child’s age and
compliance and on the practitioner’s preference. More than
80% of the examinations were performed by the hospital’s
ophthalmologists (J.Fand L.K.), the remaining ones being
conducted by private practitioners. The findings were docu-
mented prospectively using standardized forms. The results
were reviewed retrospectively. Visual acuity was consid-
ered to be normal if it lay above 20/25 using Snellen
charts, or above 2 using the Parinaud Visual Acuity Test-
ing system in children below 3 years of age. In these latter
cases, the values were age-adjusted according to standard-
ized norms [2]. In accordance with Mets et al. [12], a
visual acuity below 20/40 was deemed to represent a sub-
stantial visual impairment in our present study. Visual-
field handicaps were assessed anamnestically and using a
confrontation test. For our analysis, we extracted data re-
lating to the date of the examination, to visual acuity, to the
date of occurrence of each new ocular manifestation, and
to the size, location, activity, course of development and
treatment of each new event. The reactivation of an ex-
isting lesion and the detection of a new one were con-
sidered as new ocular events.
The information gleaned was introduced into a comput-
erized database, which already contained the date of mater-
nal infection (in weeks of gestation), particulars respecting
the treatment strategy (time of onset, nature and dosage)
during pregnancy and after birth, and the results of an-
tenatal tests (foetal ultrasonography; foetal blood and am-
niotic fluid analyses) and of neonatal ones (umbilical cord
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and peripheral blood analyses; neurological and radio-
logical examinations).
Statistical analysis
The statistical analysis was performed using SPSS (SPSS
for Windows, version 10.0; SPSS, Chicago, IL, USA). A p
value below 0.05 was considered to reveal a significant
difference.
Results
Our analysis was based on data derived from 430 consec-
utive children with congenital toxoplasmosis, of whom
103 were born before 1989 and 327 in or after 1989. At
the time of the most recent clinical and ophthalmological
check-up, which occurred after a median follow-up of
8 years (range 7 months to 26 years), 284 of the 430 sub-
jects (66%) were free of ocular or neurological lesions.
Sixteen manifested at least one neuropathological con-
dition (hydrocephalus, cerebral calcifications, convulsions,
paresis or epilepsy) without any ocular involvement.
Amongst these 300 children without ocular involvement,
2% had a moderate impairment of visual function due to
refractive abnormalities, but without evidence of ocular
toxoplasmosis.
The remaining 130 children (30.2%) exhibited ocular
pathologies that were attributable to congenital toxoplas-
mosis (Table 1). Seventy-two of these individuals (55.4%)
were males. One hundred and eight had been treated pre-
natally as well as postnatally, 19 only postnatally, and 3 had
undergone no treatment. Fifty-one of these 130 children
(39%) were born before 1989 and 79 (61%) in or after 1989
(p<0.0001; Table 2). Twenty-five of these 130 (19%) man-
ifested neurological pathologies: 24 had intracranial cal-
cifications; of these, four also had epileptic manifestations
and one had atrophy of the cortex. Hydrocephalus occurred
in three children, of whom the youngest had psychomotor
retardation; the other two had intracranial calcifications.
All of these 130 children manifested at least one chorio-
retinal lesion (retinochoroiditis). Only 39 children (30%)
were examined by direct ophthalmoscopy. Retinochoroid-
itis was bilateral in 46 of the individuals (35.4%) at the time
of the most recent examination. A total of 286 foci were
diagnosed during the follow-up period, with a mean
number of two per patient (range 1–12). Twenty-two foci
were detected at birth in 18 children. These foci involved
only one eye in 14 cases and both eyes in 4. Of these 18
patients, half were born after 1989 (9/327) and half before
1989 (9/103; p=0.02). Information concerning clinical ac-
tivity, the occurrence of chorioretinal lesions and the di-
ameter of the 286 foci is summarized in Table 3. The
proportions of active lesions detected at birth (23%) or later
(17%) were comparable (p=0.264). Lesions detected at the
time of birth were mostly macular (64%), whereas those
detected at a later stage were peripheral in 60% of cases
(p=0.003; Table 3). Among the 286 lesions, 15 (5.2%) were
reactivations (relapses or new lesions developing in a for-
merly healthy location).
Additional ocular pathologies were detected in 25 (19%)
of the 130 children with retinochoroiditis. Sixteen (64%) of
these were males (p=0.377). The median duration of fol-
low-up in these 25 patients was 13 years and 4 months
(range 2–25 years). The median and mean ages of the chil-
dren at the time of the detection of these associated pa-
thologies were 1.5 years and 5.7 years, respectively. In all
but four of the children, the associated pathologies were
detected after the diagnosis retinochoroiditis (mean 42
months, median 6 months). In the four exceptions, strabis-
mus (three cases) and microphthalmia (one case) had been
diagnosed on average 16.5 months (median 14.5 months)
before the detection of the retinochoroiditis.
Pathologies associated with retinochoroiditis are pre-
sented in Table 4. In 17 instances, a single additional
condition was detected (strabismus: 14 cases; unilateral
microphthalmia: one case; optic nerve atrophy: one case;
juxtafoveolar choroidal neovascularization secondary to a
retinal scar: one case). Five children had two associated
Table 1 Age of children at the most recent examination, together
with the total number of individuals monitored and the number
manifesting ocular pathologies associated with retinochoroiditis
Age
(years)
Number of
children (%)
Number (%) of children with
associated ocular pathologies
0.6–4 20 (15.4) 4 (16)
5–10 38 (29.2) 6 (24)
11–16 48 (36.9) 5 (20)
17–26.2 24 (18.5) 10 (40)
Total 130 (100) 25 (100)
Table 2 The incidences of ocular lesions in children with con-
genital toxoplasmosis presented according to the individual’s date of
birth (before and after 1989)
Date
of
birth
Number of
children
with no
ocular
lesion
Number of
children with
retinochoroiditis
but no other
ocular pathology
Number of children
with retinochoroiditis
and other associated
ocular pathologies
Total
Before
1989
52 39 12 103
During
or
after
1989
248 66 13 327
Total 300 105 25 430
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pathologies (strabismus and microphthalmia in four in-
stances; retinal detachment and concomitant cataracts in
one). The three remaining childrenwere severely affected by
three or more pathologies.
Of the 21 children with strabismus, 18 (86%) had a mac-
ular retinochoroiditis. Among the other three cases, the
strabismus was secondary to atrophy of the optic nerve in
one instance. In the second child, the fundus was obscured
by a cataract; in the third, amblyopia occurred indepen-
dently of any organic pathology. Four children had cata-
racts, which were unilateral in three instances and bilateral
in one. None of the children underwent cataract surgery
because of the poor visual prognosis. In the one child with
bilateral cataracts, visual acuity was below 20/200 in one
eye and only 20/100 in the other, due to the pre-existing
bilateral macular retinochoroiditis. Although the visual im-
pairment occurred prior to cataract formation, this later
condition might nevertheless have compounded the visual
handicap by narrowing the visual field. None of the re-
maining children with a unilateral cataract could perceive
light, owing to either a concomitant retinal detachment (two
cases) or a presumed severe panuveitis (one case). The two
children with tractional retinal detachment that was asso-
ciated with a chorioretinal-lesion-induced formation of fi-
brous tissue within the vitreous presented with proliferative
vitreoretinopathy grade D. These individuals likewise un-
derwent no surgery.
A comparison between the 25 children with associated
ocular pathologies and the 105 without revealed significant
differences relating to prenatal (p=0.566) or postnatal (p=
0.476) treatment. The median age at which the first cho-
rioretinal focus was detected was lower in the former group
(0.6 years, range 0–12.5 years) than in the latter [2.5 years,
range 0–21 years; p=0.085). In addition, children with
macular involvement manifested associated pathologies
more frequently than did those without (p=0.0003). Fur-
thermore, 80% (20/25) of the children in the first group had
macular lesions, compared to only 37% (39/105) in the
second (p<0.0001). Visual impairment occurred in 19 eyes
amongst 17 children (68%) with associated pathologies,
but in only 14 eyes amongst the 105 children (13%) in the
other group (p<0.001; Table 5).
In all but three cases, visual impairment was attributable
not to an associated pathology but to central (macular)
retinochoroiditis. All 14 patients without associated pathol-
ogies and with a visual acuity below 20/40 presented with
a macular lesion. Among the 15 patients with associated
Table 3 Clinical activity and anatomical characteristics of chorio-
retinal lesions in children with congenital toxoplasmosis
Status
at birth
Evolution during
the follow-up period
Retinochoroiditis
(number of foci)
22 264 (additional)
Activity at detectiona
Scar 17 (77%) 211 (83%)
Active focus 5 (23%) 43 (17%)
Location of focusb
Peripheral 6 (27%) 145 (60%)
Macular 14 (64%) 70 (29%)
Juxtapapillary 2 (9%) 27 (11%)
Size of lesion (in optic disc diameters)c
<1 3 (14%) 108 (44%)
1–2 6 (27%) 56 (23%)
2–3 7 (32%) 40 (16.5%)
3–4 6 (27%) 30 (12.5%)
4–10 – 7 (3%)
10–15 – 1 (0.5%)
>15 – 1 (0.5%)
aTen cases were excluded during the follow-up period due to lack of
information
bTwenty-four cases were excluded during the follow-up period due
to lack of information
cTwenty-one cases were excluded during the follow-up period due
to lack of information
Table 4 Ocular pathologies
associated with retinochoroiditis
in children with congenital
toxoplasmosis
aIn one patient with iridocyclitis,
cataracts, strabismus and mi-
crophthalmia, the fundus was
obscured by the uveitis-asso-
ciated cataract
– Not applicable
Clinical findings Unilateral
retinochoroiditis
Bilateral
retinochoroiditis
Total number
(%) of
affected
children
Median age
(and range)
at the time
of detection
(years)
Unilateral
associated
pathologies
Unilateral
associated
pathologies
Bilateral
associated
pathologies
Strabismus 9 11 1 21 (16) 1 (0–17)
Microphthalmia 4 3 – 7 (5.4) 2 (0.2–14.5)
Cataract 1 2 1 4 (3) 12 (0–17)
Retinal detachment 1 1 – 2 (1.5) 12 (11.5–12.5)
Optic nerve atrophy 1 1 – 2 (1.5) 7.5 (1–15)
Iridocyclitis – 2a – 2 (1.5) 5.5 (0–11)
Nystagmus – – 1 1 (0.8) 17
Neovascular glaucoma – 1 – 1 (0.8) 13
Choroidal neovascularization 1 – – 1 (0.8) 7
Total affected children 12 11 2 25/130 (19) –
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manifestations and unilateral visual impairment, 12 had
poor vision due to macular involvement and only three due
to associated pathologies (one with atrophy of the optic
nerve; one with retinal detachment and an associated
cataract; one with an obscured fundus due to cataract
formation). Only two children presented with bilateral vi-
sual impairment. Although they had associated pathologies
in both eyes, visual impairment was due to bilateral mac-
ular lesions, since the latter were detected before the as-
sociated pathologies became manifest.
Discussion
The purpose of our study was to determine the nature of the
ocular pathologies that are associated with congenital toxo-
plasmosis and to assess the impact of these events on visual
function. The 130 children comprising our population had
confirmed congenital toxoplasmosis and at least one cho-
rioretinal lesion. In most cases, the lesions were quiescent
scars at the time of their detection, which accords with
literature findings [12]. No correlation existed between the
activity of a lesion and the time of its detection (at birth or
thereafter). Foci detected at birth were more frequently
located at the posterior pole than were those revealed at a
later stage (p=0.003). This difference reflects the method
adopted for examining the fundus and the child’s compli-
ance. In the first instance, direct ophthalmoscopy is not the
best technique for thoroughly examining the periphery of a
newborn infant’s fundus, even if it is an excellent method
for precisely analysing the posterior pole. Moreover, a
child’s compliance is known to improve considerably with
age. In our study, we included older children than have
been considered in other reports dealing with this topic [1,
20], in order to increase the sample size. We were, of
course, aware that these older individuals were more likely
to be severely infected than younger ones, owing to dif-
ferences in the selection criteria adopted during earlier
times. However, we expected associated pathologies to be
rare events compared to retinochoroiditis. As anticipated,
the severity of the ocular lesions detected at birth was
significantly greater in children born before 1989, due to
the referral basis. This finding underlines the importance of
the inclusion criteria in studies addressing the natural
history of ocular findings in congenital toxoplasmosis. Al-
though we may have overestimated the frequency of as-
sociated pathologies, these were nevertheless uncommon
events.
In our series, 25 of the 130 children (19%) manifested
associated ocular pathologies. Most of the children pre-
sented with only one associated ocular manifestation; but
in one eye, we detected up to seven pathological events. In
these 25 patients, macular involvement, and thus severe
visual impairment, were more frequent than in the 105
patients without associated pathologies, which is consistent
with the findings of other investigators [12]. However, in
all but three cases, associated pathologies were not re-
sponsible for the visual impairment. Furthermore, macular
involvement was regularly diagnosed before the associated
pathology became manifest. Indeed, macular lesions were
found to be a risk factor for the development of non-retinal
ocular pathologies. This finding is, however, not surpris-
ing, since most of the associated pathologies developed as a
consequence of the chorioretinal lesions, which thus serve
as an indirect marker of the severity of congenital ocular
toxoplasmosis. Further evidence for this deduction is af-
forded by the fact that retinochoroiditis tended to appear
earlier in children with associated pathologies, probably
due to a more severe foetal contamination.
The overall proportion of associated pathologies (19%),
as well as the fairly low incidence of severe functional
damage, lay well below the values reported by other in-
vestigators [4, 11, 12, 18], and visual acuity was better.
Only 23.8% of our patients (31/130) had a significant
unilateral or bilateral visual impairment (Table 5), com-
pared to 56% (53/94) [12] and 58% (7/12) [8] in other
studies. Patients with bilateral visual impairment repre-
sented 1.5% (2/130) of our cases, compared to 28.7%
(27/94) of those in a previous report [12]. This discrepancy
may be partially explained by differences in sample size.
Table 5 Visual acuity, macular
involvement and associated oc-
ular pathologies in congenital
toxoplasmosis
aIn one patient with iridocyclitis,
cataracts, strabismus and mi-
crophthalmia, the fundus was
obscured by the uveitis-asso-
ciated cataract
Visual acuity Macular
involvement
Number (%) of
patients with
retinochoroiditis
but no associated
pathologies
Number (%) of
patients with
retinochoroiditis
and associated
pathologies
Total number
(%) of patients
Visual acuity >20/40 Yes 25 (24) 6 (24) 99 (76.2)
No 66 (63) 2 (8)
Unilateral visual
impairment (<20/40)
Yes 14 (13) 12 (48) 29 (22.3)
No 0 3a (12)
Bilateral visual
impairment (<20/40)
Yes 0 2 (8) 2 (1.5)
No 0 0
Total Yes 39/105 (37) 20/25 (80) 130 (100)
No 66/105 (63) 5a/25 (20)
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However, this factor has to be weighed against the rel-
atively short time for which patients were monitored in the
earlier studies (Table 6). Treatment of children during the
prenatal period may represent only one of several con-
tributing factors. A recent report claims that prenatal anti-
biotic therapy for congenital toxoplasmosis reduces the rate
and severity of adverse sequelae amongst infected infants
[6]. However, treatment efficacy was not assessed in this
study. Another factor that may contribute to differences in
results is selection bias. Earlier studies were mostly retro-
spective in design and included only referred patients with
a symptomatic disease condition (Table 5). The large num-
ber of ophthalmologists involved in our survey might ar-
guably have introduced a bias into the observations, but
since we used standardized data entry forms, this factor was
probably negligible.Moreover, each patient underwentmany
examinations during the course of the follow-up period,
therebyminimizing any bias. Furthermore, 80% of themore
recent examinations were performed by only two ophthal-
mologists (J.F. and L.K.).
The proportion of individuals with visual impairment in
our “control” group of 300 children with congenital toxo-
plasmosis but with no ocular lesions (2%) accords with that
in populations of normal children [9, 10]. Hence, congen-
ital toxoplasmosis appears to affect visual function only if
retinochoroiditis develops.
The duration of the follow-up in our series was suf-
ficiently long to permit an analysis of the proportion of
associated ocular pathologies. Indeed, the median andmean
ages at which these conditions were diagnosed were 1.5 and
Table 6 Clinical manifestations of congenital toxoplasmosis in previous studies and in our own series
Mets et al. [12]
(treated patients)
Mets et al. [12]
(historical patients)
Vutova et al. [18]
(historical patients)
Meenken et al. [11]
(institute for
handicapped children)
Present series
(treated patients)
Number of patients 76 18 38 17 130
Number of patients
with ocular
pathologies
associated with
retinochoroiditis (%)
NI >26 (>34) NI >7 (>39) 28 (74) NI >13 (>76.5) 25 (19)
Follow-up (median) 5 years 11 years NI 27 years (mean) 12 years
Study design Prospective Retrospective Cross-sectional Retrospective Prospective
Selection criterion Referral basis Referral basis Referral basis Severe congenital
toxoplasmosis
Prenatal screening
Prenatal treatment 9: yes no no no 108: yes
67: no 22: no
Postnatal treatment yes no no 9: yes 127: yes
8: no 3: no
Strabismus (%) 26 (34) 5 (28) 10 (26) 13 (76.5) 21 (16)
Microphthalmia (%) 10 (13) 2 (11) 10 (26) 10 (59) 7 (5.4)
Cataract (%) 7 (9) 2 (11) 6 (16) 9 (53) 4 (3)
Retinal detachment
(%)
7 (9) 2 (11) 4 (11) 2 (11.8) 2 (1.5)
Optic nerve
atrophy (%)
14 (18) 5 (28) – 13 (76.5) 2 (1.5)
Iridocyclitis (%) – – 2 (5) – 2 (1.5)
Nystagmus (%) 20 (26) 5 (28) 3 (8) – 1 (0.8)
Glaucoma (%) – – 6 (16) 1 (5.9) 1 (0.8)
Choroidal
neovascularization (%)
1 (1.3) – – – 1 (0.8)
Global atrophy (%) 4 (5) 0 – – 0
Visual acuity below
20/40 (%)
61/152 eyes (40.1) 19/36 eyes (52.8) NIa 33/34 eyes (97.1) 33/260 eyes (12.7)
Macular
involvement (%)
55/144 eyes (38) 16/34 eyes (47) 9/76 eyes (12) NI 61/260 eyes (23)
a26% with substantial visual impairment but no additional information
NI=not indicated
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5.7 years, respectively, which lie within the follow-up time
for 84% of our children.
Of the associated ocular pathologies, some were due to
the retinochoroiditis, whereas others were either due di-
rectly to, or were coincidentally associated with, congenital
ocular toxoplasmosis. Of the associated pathologies, stra-
bismus (eso- or exotropia) was the condition most fre-
quently encountered (21%),which accordswith the findings
of other investigators [4, 11, 12, 18]. Most of the strabismus
cases were attributable to poor vision, which, in turn, was
attributable to macular lesions in 86% of cases. Only one
child presented with strabismus and amblyopia that were
unrelated to any organic pathology. These results accord
with literature findings, since strabismus is encountered
in only about 3% of cases in unselected cohorts of safe
children [10, 13]. Nystagmus was encountered in one child
and may have been attributable either to cerebral involve-
ment or to visual impairment (due to a central focus).
Atrophy of the optic nerve may result from toxoplasmic
papillitis. In the absence of chorioretinal scars, this aetiology
may be easily overlooked [5]. Indeed, in the two children
with atrophy of the optic nerve, no active focus or scar was
visible adjacent to the head of the optic nerve. However,
chorioretinal lesions were present in both children. Four
peripheral scars were detected in the first child and a single
macular one in the second. One of the children also pre-
sented with atrophy of the cortex without hydrocephalus;
the other manifested no neurological abnormalities. There
was no obvious reason for the optic nerve atrophy. Hence,
we can only assume, along with other investigators, that it is
related to the preceding papillitis [15, 17, 21]. Retinal de-
tachment, cataracts, neovascular glaucoma and choroidal
neovascularization most frequently developed as a result of
chorioretinal foci. Chorioretinal inflammation may occur in
conjunction with vitreal infiltration and secondary traction,
leading ultimately to rhegmatogenous retinal detachment
[7, 16]. Mets et al. reported cataracts to be unilateral in two-
thirds of their cases (6/9) [12]. Two of these children un-
derwent cataract surgery. In both instances extensive cho-
rioretinal scarring was disclosed after cataract extraction,
and a long-standing retinal detachment was presumed to
have existed in both cases. Hence, the visual prognosis for
such children is not good [12]. In our series, none of the
children underwent lens replacement if macular involve-
ment was bilateral, or if the patient was unable to perceive
light. Microphthalmia and iridocyclitis are due directly to
congenital toxoplasmosis, the former being the secondmost
frequent manifestation in our series.
In conclusion, the proportion of associated ocular pa-
thologies disclosed in the present series was lower than
expected on the basis of literature findings and the visual
outcome was better, despite the inclusion of older children.
Our data revealed associated pathologies to appear later
than retinochoroiditis, and this delay has not been pre-
viously described. Associated pathologies occurred more
frequently in eyes with macular involvement, but they did
not directly influence visual acuity. Associated pathologies
serve as an indirect marker of the severity of congenital
ocular toxoplasmosis, in that children thus affected man-
ifested a higher incidence of macular involvement leading
to visual impairment. Since associated ocular pathologies
may arise late in life and yet be unforeseeable, long-term
follow-up is essential to assess the ocular impact of con-
genital toxoplasmosis, particularly in children with macu-
lar lesions caused by retinochoroiditis. Parents should be
informed of the risk not only of retinochoroiditis, but also
of associated pathologies and their consequences. They
should also be made aware of the necessity of a long-term
follow-up. In our series, however, the overall functional
prognosis of congenital toxoplasmosis is more satisfactory
than that based on earlier findings, with only two of the 130
children having a bilateral impairment of visual function.
The impact of retinochoroiditis and of associated eye pa-
thologies on the life quality of children with congenital
toxoplasmosis must now be assessed.
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